These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 31388776

  • 21. Appendiceal goblet cell carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Randle RW, Griffith KF, Fino NF, Swett KR, Stewart JH, Shen P, Levine EA, Votanopoulos KI.
    J Surg Res; 2015 Jun 15; 196(2):229-34. PubMed ID: 25881787
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. What is the Optimal Preoperative Imaging Modality for Assessing Peritoneal Cancer Index? An Analysis From the United States HIPEC Collaborative.
    Lee RM, Zaidi MY, Gamboa AC, Speegle S, Kimbrough CW, Cloyd JM, Leiting JL, Grotz TE, Lee AJ, Fournier KF, Powers BD, Dineen SP, Baumgartner J, Veerapong J, Clarke CN, Sussman JJ, Patel S, Hendrix RJ, Lambert LA, Vande Walle KA, Abbott DE, LaRocca CJ, Raoof M, Fackche N, Johnston FM, Staley CA, Maithel SK, Russell MC.
    Clin Colorectal Cancer; 2020 Mar 15; 19(1):e1-e7. PubMed ID: 31974019
    [Abstract] [Full Text] [Related]

  • 24. Histologic Predictors of Recurrence in Mucinous Appendiceal Tumors with Peritoneal Dissemination after HIPEC.
    Reghunathan M, Kelly KJ, Valasek MA, Lowy AM, Baumgartner JM.
    Ann Surg Oncol; 2018 Mar 15; 25(3):702-708. PubMed ID: 29282599
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Long term survival analysis after hyperthermic intraperitoneal chemotherapy with oxaliplatin as a treatment for appendiceal peritoneal carcinomatosis.
    Masckauchan D, Trabulsi N, Dubé P, Aubé-Lecompte ME, Cloutier AS, Mitchell A, Sideris L.
    Surg Oncol; 2019 Mar 15; 28():69-75. PubMed ID: 30851915
    [Abstract] [Full Text] [Related]

  • 27. Cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis secondary to mucinous adenocarcinoma of the appendix.
    Sparks DS, Morris B, Xu W, Fulton J, Atkinson V, Meade B, Lutton N.
    Int Surg; 2015 Jan 15; 100(1):21-8. PubMed ID: 25594636
    [Abstract] [Full Text] [Related]

  • 28. Importance of Absent Neoplastic Epithelium in Patients Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Enblad M, Birgisson H, Wanders A, Sköldberg F, Ghanipour L, Graf W.
    Ann Surg Oncol; 2016 Apr 15; 23(4):1149-56. PubMed ID: 26577120
    [Abstract] [Full Text] [Related]

  • 29. Extensive surgical history prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is associated with poor survival outcomes in patients with peritoneal mucinous carcinomatosis of appendiceal origin.
    Milovanov V, Sardi A, Aydin N, Nieroda C, Sittig M, Nunez M, Gushchin V.
    Eur J Surg Oncol; 2015 Jul 15; 41(7):881-5. PubMed ID: 25899982
    [Abstract] [Full Text] [Related]

  • 30. Mucinous tumor of the appendix with limited peritoneal spread: is there a role for expectant observation?
    Zih FS, Wong-Chong N, Hummel C, Petronis J, Panzarella T, Pollett A, McCart JA, Swallow CJ.
    Ann Surg Oncol; 2014 Jan 15; 21(1):225-31. PubMed ID: 24100959
    [Abstract] [Full Text] [Related]

  • 31. Perioperative systemic chemotherapy for peritoneal mucinous appendiceal carcinomas treated with cytoreductive surgery & HIPEC.
    Spiliotis J, Kopanakis N, Efstathiou E, Vassiliadou D, Argiriou O, Rogdakis A, Valavanis C.
    J BUON; 2017 Jan 15; 22(3):783-789. PubMed ID: 28730790
    [Abstract] [Full Text] [Related]

  • 32. Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.
    Vassos N, Förtsch T, Aladashvili A, Hohenberger W, Croner RS.
    World J Surg Oncol; 2016 Feb 24; 14(1):42. PubMed ID: 26912149
    [Abstract] [Full Text] [Related]

  • 33. Incomplete cytoreduction with peritoneal metastases from appendiceal mucinous neoplasms.
    Sugarbaker PH, Chang D.
    J Surg Oncol; 2022 Dec 24; 126(8):1462-1470. PubMed ID: 36102369
    [Abstract] [Full Text] [Related]

  • 34. Hyperthermic intraperitoneal chemotherapy + early postoperative intraperitoneal chemotherapy versus hyperthermic intraperitoneal chemotherapy alone: assessment of survival outcomes for colorectal and high-grade appendiceal peritoneal carcinomatosis.
    Lam JY, McConnell YJ, Rivard JD, Temple WJ, Mack LA.
    Am J Surg; 2015 Sep 24; 210(3):424-30. PubMed ID: 26051744
    [Abstract] [Full Text] [Related]

  • 35. Volume-Time Index Is Not an Indicator of Outcome for Patients Undergoing CRS/HIPEC for Treatment of High-Grade Appendiceal Carcinomatosis.
    Dotta DM, Lansom JD, Fisher OM, Fracs NAA, Liauw W, Morris DL.
    Anticancer Res; 2019 Dec 24; 39(12):6813-6817. PubMed ID: 31810947
    [Abstract] [Full Text] [Related]

  • 36. PCI is Not Predictive of Survival After Complete CRS/HIPEC in Peritoneal Dissemination from High-Grade Appendiceal Primaries.
    Votanopoulos KI, Bartlett D, Moran B, Haroon CM, Russell G, Pingpank JF, Ramalingam L, Kandiah C, Chouliaras K, Shen P, Levine EA.
    Ann Surg Oncol; 2018 Mar 24; 25(3):674-678. PubMed ID: 29288288
    [Abstract] [Full Text] [Related]

  • 37. Repeat cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal carcinomatosis of appendiceal origin.
    Kitai T, Yamanaka K.
    Int J Clin Oncol; 2018 Apr 24; 23(2):298-304. PubMed ID: 29181652
    [Abstract] [Full Text] [Related]

  • 38. Management of an inguinal hernia in patients with pseudomyxoma peritonei.
    Sugarbaker PH.
    Eur J Surg Oncol; 2017 Jun 24; 43(6):1083-1087. PubMed ID: 28131668
    [Abstract] [Full Text] [Related]

  • 39. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: an emerging treatment option for advanced goblet cell tumors of the appendix.
    McConnell YJ, Mack LA, Gui X, Carr NJ, Sideris L, Temple WJ, Dubé P, Chandrakumaran K, Moran BJ, Cecil TD.
    Ann Surg Oncol; 2014 Jun 24; 21(6):1975-82. PubMed ID: 24398544
    [Abstract] [Full Text] [Related]

  • 40. P.R.O.P.S. - A novel Pre-Operative Predictive Score for unresectability in patients with colorectal peritoneal metastases being considered for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Yong ZZ, Tan GHC, Shannon N, Chia C, Teo MCC.
    World J Surg Oncol; 2019 Aug 07; 17(1):138. PubMed ID: 31391066
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.